| Literature DB >> 25964812 |
Jose Manuel Sarabia1, Jaime Fernandez-Fernandez1, Casto Juan-Recio1, Hector Hernández-Davó1, Tomás Urbán1, Manuel Moya1.
Abstract
This study examined the effects of a 6-week non-failure strength training program in youth tennis players. Twenty tennis players (age: 15.0 ± 1 years, body height: 170.9 ± 5.1 cm, body mass: 63.3 ± 9.1 kg) were divided into experimental and control groups. Pre and post-tests included half squats, bench press, squat jumps, countermovement-jumps and side-ball throws. Salivary cortisol samples were collected, and the Profile of Mood States questionnaire was used weekly during an anatomical adaptation period, a main training period and after a tapering week. The results showed that, after the main training period, the experimental group significantly improved (p<0.05) in mean and peak power output and in the total number of repetitions during the half-squat endurance test; mean force, power and velocity in the half-squat power output test; Profile of Mood States (in total mood disturbance between the last week of the mean training period and the tapering week); and in squat-jump and countermovement-jump height. Moreover, significant differences were found between the groups at the post-tests in the total number of repetitions, mean and peak power during the half-squat endurance test, mean velocity in the half-squat power output test, salivary cortisol concentration (baselines, first and third week of the mean training period) and in the Profile of Mood States (in fatigue subscale: first and third week of the mean training period). In conclusion, a non-failure strength training protocol improved lower-limb performance levels and produced a moderate psychophysiological impact in youth elite tennis players, suggesting that it is a suitable program to improve strength. Such training protocols do not increase the total training load of tennis players and may be recommended to improve strength.Entities:
Keywords: cortisol; mood states; power output; resistance training; youth athletes
Year: 2015 PMID: 25964812 PMCID: PMC4415846 DOI: 10.1515/hukin-2015-0009
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Figure 1Experimental design.
Mean ± SD values of upper body strength tests performed during T1 and T2.
| Side Ball throw | Dominant side (m) | EG | 9.37 ± 1.01 | 10.60 ± 1.01 [ | 0.49 |
| CG | 9.51 ± 1.56 | 10.07 ± 1.71 | 0.18 | ||
| Non-dominant side (m) | EG | 9.07 ± 0.78 | 9.86 ± 1.06 [ | 0.42 | |
| CG | 9.46 ± 1.56 | 9.72 ± 1.40 | 0.06 | ||
|
| |||||
| W-PRESS | Velocity (m·s−1) | EG | 0.55 ± 0.09 | 0.58 ± 0.08 | 0.09 |
| CG | 0.61 ± 0.14 | 0.62 ± 0.13 | 0.01 | ||
| Force (N) | EG | 328.0 ± 41.8 | 341.1 ± 48.8 | 0.30 | |
| CG | 285.2 ± 68.6 | 294.7 ± 68.7 | 0.37 | ||
| Power (W) | EG | 182.1 ± 41.8 | 194.1 ± 39.6 | 0.14 | |
| CG | 170.2 ± 47.8 | 184.2 ± 74.8 | 0.09 | ||
|
| |||||
| END-PRESS | Rep. until failure | EG | 15.0 ± 5.6 | 23.7 ± 9.4 | 0.56 |
| CG | 8.6 ± 6.0 | 8.3 ± 2.4 | 0.41 | ||
| Rep. not leading to failure | EG | 7.7 ± 3.2 | 11.0 ± 5.6 | 0.50 | |
| CG | 6.4 ± 5.9 | 6.7 ± 1.8 | 0.11 | ||
| Peak power (N) | EG | 383.0 ± 104.4 | 514.7 ± 124.2 | 0.29 | |
| CG | 360.7 ± 105.7 | 379.1 ± 86.9 | 0.50 | ||
| Mean power (N) | EG | 375.1 ± 102.5 | 500.4 ± 118.4 | 0.28 | |
| CG | 345.5 ± 103.2 | 368.1 ± 82.9 | 0.54 | ||
W-PRESS = Bench press power output test;
END-PRESS= Bench press endurance test.
Significant differences from T1. p < 0.05;
Significant differences from T1. p < 0.01
Mean ± SD values of lower limb tests performed during T1 and T2, and effect sizes (ES)
| T1 | T2 | ES (η2) | |||
|---|---|---|---|---|---|
| Jump Tests | SJ (cm) | EG | 28.45 ± 3.61 | 31.18 ± 2.27 [ | 0.54 |
| CG | 31.71 ± 4.68 | 33.28 ± 3.59 | 0.38 | ||
| CMJ (cm) | EG | 31.18 ± 3.57 | 32.45 ± 2.33 [ | 0.34 | |
| CG | 33.85 ± 3.57 | 33.57 ± 4.46 | 0.02 | ||
|
| |||||
| W-SQUAT | Velocity (m·s−1) | EG | 0.57 ± 0.09 | 0.62 ± 0.13 [ | 0.36 |
| CG | 0.55 ± 0.02 | 0.50 ± 0.06 | 0.40 | ||
| Force (N) | EG | 627.9 ± 183.1 | 685.1 ± 181.8 [ | 0.51 | |
| CG | 700.8 ± 231.0 | 700.1 ± 231.4 | 0.23 | ||
| Power (W) | EG | 351.6 ± 91.8 | 405.0 ± 105.2 [ | 0.42 | |
| CG | 380.8 ± 117.1 | 347.7 ± 111.4 | 0.38 | ||
|
| |||||
| END-SQUAT | Rep. until failure | EG | 14.9 ± 5.6 [ | 23.73 ± 9.36 [ | 0.73 |
| CG | 8.6 ± 6.0 | 8.29 ± 2.43 | 0.01 | ||
| Rep. not leading to failure | EG | 7.6 ± 3.2 | 11.0 ± 5.6 | 0.37 | |
| CG | 6.4 ± 5.9 | 6.7 ± 1.8 | 0.01 | ||
| Peak power (N) | EG | 383.0 ± 104.4 | 514.7 ± 124.2 [ | 0.60 | |
| CG | 360.7 ± 105.7 | 379.1 ± 86.9 | 0.07 | ||
| Mean power (N) | EG | 375.1 ± 102.5 | 500.4 ± 118.3 [ | 0.58 | |
| CG | 345.5 ± 103.2 | 368.1 ± 81.9 | 0.11 | ||
SJ = Squat jump; CMJ = Countermovement Jump;
W-SQUAT = Parallel half-squat power output test;
END-SQUAT= Parallel half-squat endurance test.
Significant differences from T1. p < 0.05;
Significant differences from T1. p < 0.01;
Significant differences in the CG. p < 0.05;
Significant differences in the CG. p < 0.01
Figure 2Mean values of saliva cortisol concentrations during the intervention period.
*Significant differences in the CG. p < 0.05.
Figure 3(a) Fatigue subscale score POMS. Total mood disturbance during the intervention period (b).
*Significant differences in the CG. p < 0.05; ‖Significant differences between weeks. p < 0.01